Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus.

× No keyword cloud information.

28 in total

1. Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups.

Authors: Stuart A Scott; Rame Khasawneh; Inga Peter; Ruth Kornreich; Robert J Desnick
Journal: Pharmacogenomics Date: 2010-06 Impact factor: 2.533

Review 2. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.

Authors: Ron H N van Schaik
Journal: Invest New Drugs Date: 2005-12 Impact factor: 3.850

3. Allele and genotype frequencies of CYP2C9 in a Korean population.

Authors: Jung-Woo Bae; Hyun-Kyung Kim; Ji-Hong Kim; Sang-In Yang; Mi-Jeong Kim; Choon-Gon Jang; Young-Seo Park; Seok-Yong Lee
Journal: Br J Clin Pharmacol Date: 2005-10 Impact factor: 4.335

4. Novel CYP2C9 promoter variants and assessment of their impact on gene expression.

Authors: Melissa A Kramer; Allan E Rettie; Mark J Rieder; Erwin T Cabacungan; Ronald N Hines
Journal: Mol Pharmacol Date: 2008-02-29 Impact factor: 4.436

5. In vitro functional characterization of 37 CYP2C9 allelic isoforms found in Chinese Han population.

Authors: Da-peng Dai; Yu-han Wang; Shuang-hu Wang; Pei-wu Geng; Li-ming Hu; Guo-xin Hu; Jian-ping Cai
Journal: Acta Pharmacol Sin Date: 2013-09-30 Impact factor: 6.150

6. Analysis of CYP2C9 polymorphisms (2 and 3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (2 and3) with warfarin dose, age, PT and INR.

Authors: Faiza Yasmeen; Muhammad Bilal Ghafoor; Abdul Wadood Khalid; Waqas Latif; Shahida Mohsin; Shagufta Khaliq
Journal: J Thromb Thrombolysis Date: 2015-08 Impact factor: 2.300

Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus.

1. Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups.

Review 2. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.

3. Allele and genotype frequencies of CYP2C9 in a Korean population.

4. Novel CYP2C9 promoter variants and assessment of their impact on gene expression.

5. In vitro functional characterization of 37 CYP2C9 allelic isoforms found in Chinese Han population.

6. Analysis of CYP2C9 polymorphisms (2 and 3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (2 and3) with warfarin dose, age, PT and INR.

7. Interpretation of the effect of CYP2C9, VKORC1 and CYP4F2 variants on warfarin dosing adjustment in Turkey.

Review 8. Implications of pharmacogenetics for individualizing drug treatment and for study design.

9. CYP2C9 genetic variants and losartan oxidation in a Turkish population.

10. A case report of a patient carrying CYP2C9*3/4 genotype with extremely low warfarin dose requirement.